These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 32247028)

  • 21. Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients - A validation study in plasma and cerebrospinal fluid from two Swedish cohorts.
    Bynke A; Julin P; Gottfries CG; Heidecke H; Scheibenbogen C; Bergquist J
    Brain Behav Immun Health; 2020 Aug; 7():100107. PubMed ID: 34589868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Freitag H; Szklarski M; Lorenz S; Sotzny F; Bauer S; Philippe A; Kedor C; Grabowski P; Lange T; Riemekasten G; Heidecke H; Scheibenbogen C
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.
    Maes M
    Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
    Cabanas H; Muraki K; Eaton-Fitch N; Staines DR; Marshall-Gradisnik S
    Front Immunol; 2021; 12():687806. PubMed ID: 34326841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).
    Morris G; Berk M; Galecki P; Maes M
    Mol Neurobiol; 2014 Apr; 49(2):741-56. PubMed ID: 24068616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations.
    Mandarano AH; Maya J; Giloteaux L; Peterson DL; Maynard M; Gottschalk CG; Hanson MR
    J Clin Invest; 2020 Mar; 130(3):1491-1505. PubMed ID: 31830003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free-water-corrected diffusion and adrenergic/muscarinic antibodies in myalgic encephalomyelitis/chronic fatigue syndrome.
    Kimura Y; Sato W; Maikusa N; Ota M; Shigemoto Y; Chiba E; Arizono E; Maki H; Shin I; Amano K; Matsuda H; Yamamura T; Sato N
    J Neuroimaging; 2023; 33(5):845-851. PubMed ID: 37243973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.
    Loebel M; Grabowski P; Heidecke H; Bauer S; Hanitsch LG; Wittke K; Meisel C; Reinke P; Volk HD; Fluge Ø; Mella O; Scheibenbogen C
    Brain Behav Immun; 2016 Feb; 52():32-39. PubMed ID: 26399744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medically Documenting Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Cases.
    Comerford BB; Podell R
    Front Pediatr; 2019; 7():231. PubMed ID: 31334205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Balinas C; Cabanas H; Staines D; Marshall-Gradisnik S
    J Transl Med; 2019 Dec; 17(1):401. PubMed ID: 31796045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
    Maes M; Twisk FN; Kubera M; Ringel K
    J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
    Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A
    Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome.
    Yang CA; Bauer S; Ho YC; Sotzny F; Chang JG; Scheibenbogen C
    J Transl Med; 2018 Aug; 16(1):231. PubMed ID: 30119681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic Fatigue Exhibits Heterogeneous Autoimmunity Characteristics Which Reflect Etiology.
    Danilenko OV; Gavrilova NY; Churilov LP
    Pathophysiology; 2022 May; 29(2):187-199. PubMed ID: 35736644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW; van Driel ML; Staines DR; Ashton KJ; Ramos SB; Keane J; Klimas NG; Marshall-Gradisnik SM
    J Transl Med; 2011 May; 9():81. PubMed ID: 21619669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.
    Scherbakov N; Szklarski M; Hartwig J; Sotzny F; Lorenz S; Meyer A; Grabowski P; Doehner W; Scheibenbogen C
    ESC Heart Fail; 2020 Jun; 7(3):1064-1071. PubMed ID: 32154656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
    J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study.
    Nakatomi Y; Mizuno K; Ishii A; Wada Y; Tanaka M; Tazawa S; Onoe K; Fukuda S; Kawabe J; Takahashi K; Kataoka Y; Shiomi S; Yamaguti K; Inaba M; Kuratsune H; Watanabe Y
    J Nucl Med; 2014 Jun; 55(6):945-50. PubMed ID: 24665088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.
    Morris G; Maes M
    Metab Brain Dis; 2014 Mar; 29(1):19-36. PubMed ID: 24557875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Autonomic Function in Exercise-induced Endogenous Analgesia: A Case-control Study in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Healthy People.
    Oosterwijck JV; Marusic U; De Wandele I; Paul L; Meeus M; Moorkens G; Lambrecht L; Danneels L; Nijs J
    Pain Physician; 2017 Mar; 20(3):E389-E399. PubMed ID: 28339438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.